Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 10,994 in Johnson and Johnson

  1. More Plaintiffs Go HomeRead the original story w/Photo

    Friday Apr 17 | JD Supra

    Two days ago, we posted on a West Virginia Supreme Court decision that told non-resident plaintiffs the closing time refrain "you don't have to go home, but you can't stay here." OK, we took some liberties there, but the non-resident plaintiffs who had gone shopping in a non conveniens forum could not stay even after poking around for two years.

    Comment?

  2. Johnson & Johnson: Don't Let Foreign Exchange Cloud Your View Of This Dividend ChampionRead the original story w/Photo

    Thursday Apr 16 | Seeking Alpha

    Although growing somewhat on an operational basis, currency headwinds resulted in a 4.3% bottom line contraction during the first quarter. Still highly profitable operations suggest Johnson & Johnson could be a solid addition to dividend growth portfolios with plenty of time ahead of retirement.

    Comment?

  3. The Perfect Portfolio For Retirement Is An IllusionRead the original story w/Photo

    Friday Apr 17 | Seeking Alpha

    I will never state that my portfolio is the perfect way to go for anyone, and the choices people make for themselves are hopefully for their own unique circumstance. Don't let anyone tell you that they have found the "perfect portfolio."

    Comment?

  4. Mass. court upholds $63M judgment against maker of Children's MotrinRead the original story w/Photo

    Friday Apr 17 | Worcester Telegram & Gazette

    The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine. A jury ruled in 2013 that the McNeil Consumer Healthcare unit of Johnson & Johnson failed to provide sufficient warnings about potential side effects.

    Comment?

  5. Massachusetts court upholds $63M judgment against J&JRead the original story

    Friday Apr 17 | Boston Herald

    The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine. A jury ruled in 2013 that the McNeil Consumer Healthcare unit of Johnson & Johnson failed to provide sufficient warnings about potential side effects.

    Comment?

  6. Publishers Looking Forward To Google's New Mobile-Friendly Search AlgoRead the original story w/Photo

    Friday Apr 17 | AdExchanger.com

    On April 21, Google will begin instituting a change to its mobile search algorithm that will take a site's mobile-friendliness into account when ranking results. Indexed apps will also start showing up amongst organic search results.

    Comment?

  7. Procter & Gamble: Lean Initiatives Not Being Priced Into Shares Presents Value Buying OpportunityRead the original story w/Photo

    Friday Apr 17 | Seeking Alpha

    PG is being completely disrespected by the analyst community and is being given zero forward looking credit for its progress in leaning out its product and brand portfolio. The Procter & Gamble Company is getting zero credit for its leaning out of the company product portfolio and zero credit for the focused "up-line" expense cutting taking place.

    Comment?

  8. Merck CEO Frazier Becomes PhRMA Board ChairmanRead the original story w/Photo

    Friday Apr 17 | Pharmaceutical Processing

    Today, Kenneth C. Frazier, chairman and chief executive officer of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America . At today's Board meeting, PhRMA's president and CEO John J. Castellani announced that he will be retiring effective January 1, 2016.

    Comment?

  9. Massachusetts court upholds $63M judgment against Johnson & JohnsonRead the original story w/Photo

    Friday Apr 17 | Berkshire Eagle

    A Superior Court jury ruled in 2013 that Johnson & Johnson failed to provide sufficient warnings about the potential side effects of Motrin. Samantha Reckis was 7 in 2003 when she was given the ibuprofen product to reduce a fever.

    Comment?

  10. Court upholds large verdict against drug company for girl permanently ...Read the original story w/Photo

    Friday Apr 17 | Universal Hub

    The Supreme Judicial Court today upheld a jury decision to award a South Shore teen and her parents $63 million in damages for the permanent injuries she suffered after being given several doses of Children's Motrin when she was 7. Samantha Reckis's parents sued Johnson & Johnson, saying they never would have continued giving her the pain reliever in 2003 - or let her doctors give her even more - had they known the rash she developed after treatment for what initially seemed like a cold was a potential side effect of the drug that, in her case would turn into a life-threatening series of complications, many of them permanent.

    Comment?

  11. Judge upholds $63M ruling against Johnson & Johnson for girl's rare reactionRead the original story w/Photo

    Friday Apr 17 | The Jersey Journal

    The highest court in Massachusetts upheld a $63 million ruling against a New Jersey-based health care company for a 7-year-old's reaction to children's pain medication that nearly killed her and left her blind, according to The Boston Globe. Two years ago, Johnson & Johnson and its subsidiary were ordered by a Massachusetts Superior Court to pay Samantha Reckis, now 16, and her parents a total of $109 million including interest.

    Comment?

  12. Dividend Champions, Contenders And Challengers With 10-Year Declining Dividend Growth RatesRead the original story w/Photo

    Friday Apr 17 | Seeking Alpha

    The importance of this pattern can vary from unimportant to being a significant clue as to the desirability of a dividend growth stock. The Dividend Champions document is compiled by fellow SA author David Fish.

    Comment?

  13. SJC upholds $63m verdict in Children's Motrin caseRead the original story w/Photo

    Friday Apr 17 | Boston.com

    The highest court in Massachusetts has upheld a $63 million legal judgment against health care giant Johnson & Johnson in the case of a little girl who nearly died and was left legally blind after taking one of the country's most common household medicines, Children's Motrin. The Supreme Judicial Court issued the ruling Friday affirming a Plymouth County jury's 2013 award in the case of Samantha Reckis.

    Comment?

  14. Current management has been unable to stop the company's slide.Read the original story w/Photo

    Friday Apr 17 | TheStreet.com

    When it made its offer for Avon, it had the backing of its owner Joh. A. Benckiser GmbH, as well as Warren Buffet's Omaha-based Berkshire Hathaway Instead, the direct seller of beauty products opted to attempt a turnaround of the company under a newly appointed chief executive, Sherilyn McCoy, the former vice chairman of New Brunswick, N.J.-based health care and consumer-products conglomerate Johnson & Johnson Fast forward to about two years later: Avon continues to struggle under McCoy and is now worth $9.15 per share, giving it a market cap of almost $4 billion as of the market's close on Tuesday.

    Comment?

  15. Johnson & Johnson: A Great Company In A Great SectorRead the original story w/Photo

    Friday Apr 17 | Seeking Alpha

    This is not an invitation to buy or sell this security. Do your own research and come to your own conclusions.

    Comment?

  16. Merck & Co. Chairman And CEO Becomes PhRMA Board ChairmanRead the original story

    Thursday Apr 16 | BioSpace

    At today's Board meeting, PhRMA's president and CEO for his invaluable contributions over the last year," said Castellani. "Our member companies have never invested more in researching and developing innovative, targeted new medicines to fight life-threatening diseases.

    Comment?

  17. Surging dollar rattles world economies, marketsRead the original story w/Photo

    Thursday Apr 16 | The Gleaner

    Since June 30, the greenback is up 28 per cent against the euro, 18 per cent against the Japanese yen and 40 per cent against the Brazilian real. Not since 1981 has the dollar been so strong.

    Comment?

  18. Student's skill offers a hand to pizza-makerRead the original story w/Photo

    Thursday Apr 16 | Philly.com

    He thought about those words as he learned to ride a bike. He thought about them as he bonded with his father over cooking lessons.

    Comment?

  19. BlackBerry's Health Initiatives Might Have Hit A WallRead the original story w/Photo

    Thursday Apr 16 | Seeking Alpha

    BBRY made a healthcare-related investment last year that many saw as a great opportunity for the company to grow its user base. With IBM and AAPL's expanded partnership, and IBM's recent partnerships, BBRY might not have much hope in the $20 billion healthcare analytics market.

    Comment?

  20. Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board ChairmanRead the original story

    Thursday Apr 16 | Freshnews

    Today, Kenneth C. Frazier, chairman and chief executive officer of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America . At today's Board meeting, PhRMA's president and CEO John J. Castellani announced that he will be retiring effective January 1, 2016.

    Comment?